Opioid Use Disorder in Special Populations: Making Recovery a Goal
Premiere Date: Wednesday, October 10, 2018This activity offers CE credit for:
- Physicians (CME)
- Nurses (CNE)
- Social Workers (NASW)
- Certified Case Managers (CCMC)
- Pharmacists (ACPE)
- ABIM (MOC)
- Other
All other clinicians will receive a Certificate of Attendance stating this activity was certified for AMA PRA Category 1 Credit™
Credit Expiration Date:
Thursday, October 10, 2019
Note: Credit Is No Longer Available
 | Mark S. Gold, MD (Moderator) ASAM's Annual Lifetime Achievement John P. McGovern Award & Prize Winner Adjunct Professor of Psychiatry Washington University School of Medicine St. Louis, MO 17th University of Florida Distinguished Alumni Professor Gainesville, FL |
 | James H. Berry, DO Associate Professor and Vice Chair Director of Addictions Department of Behavioral Medicine and Psychiatry Department of Neurosciences West Virginia University School of Medicine Morgantown, WV |
 | Brian Fuehrlein, MD, PhD Associate Professor of Psychiatry Yale University School of Medicine Director, Psychiatric Emergency Room VA Connecticut Healthcare System New Haven, CT |
 | Thomas R. Kosten, MD JH Waggoner Chair and Professor of Psychiatry, Neuroscience, Pharmacology, Immunology & Pathology Director, Division of Addiction Psychiatry Baylor College of Medicine Houston, TX |
 | Tobias Wasser, MD Chief Medical Officer, Whiting Forensic Hospital Middletown, CT Assistant Professor of Psychiatry, Yale University School of Medicine Associate Director, Yale Fellowship in Public Psychiatry New Haven, CT |
The opioid epidemic is ravaging many parts of the United States, resulting in drug overdose deaths emerging as the leading cause of injury death. The 2015 statistics from Health and Human Services on human and economic costs were staggering, reporting that 12.5 million people misused prescription opioids that year, resulting in $78.5 billion in economic costs. Yet the National Institute on Alcohol Abuse and Alcoholism (NIAA)'s National Epidemiological Survey on Alcohol Abuse and Related Conditions-III showed that only about 5% of people with OUD received treatment in the past year, and only 17% ever received help such as medication and behavioral counseling.
Two populations in particular warrant attention of healthcare providers: incarcerated individuals and veterans. Approximately half of state and federal prisoners meet criteria for substance use disorder, and the number of veterans addicted to opioids rose 55% between 2010 and 2015.
This CME Outfitters Live and On Demand initiative features expert faculty working to improve recognition of the risk of relapse or death among special populations with OUD and providing information about novel programs and how to integrate them into clinical practice with patients with OUD.
At the end of this CE activity, participants should be able to:
- Recognize the risk of relapse or death among incarcerated individuals with untreated OUD upon release.
- Apply data for MAT among special populations (veterans in the VA system, incarcerated individuals) to decision-making for individuals with OUD.
- Heighten awareness of novel programs in the community to treat patients with OUD and integrate one best practice tip into clinical practice.
The following learning objectives pertain only to those requesting CNE or CPE credit:
- Recognize the risk of relapse or death among incarcerated individuals with untreated OUD upon release.
- Summarize data for MAT among special populations (veterans in the VA system, incarcerated individuals) to decision-making for individuals with OUD.
- Heighten awareness of novel programs in the community to treat patients with OUD and integrate one best practice tip into clinical practice.
Supported by educational grants from Alkermes, Inc. and Indivior Inc.
Physicians, physician assistants, nurse practitioners, nurses, and pharmacists.
CME Credit (Physicians):
CME Outfitters, LLC, is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
CME Outfitters, LLC, designates this enduring activity for a maximum of 1.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
CNE Credit (Nurses):
Provider approved by the California Board of Registered Nursing, Provider Number CEP 15510, for 1.5 contact hours.
Note to Nurse Practitioners and Clinical Nurse Specialists: the content of this activity pertains to pharmacology. Earn up to 1.5 contact hours of pharmacotherapeutic contact hours.
Note to Nurse Practitioners: Nurse Practitioners can apply for AMA PRA Category 1 Credit™ through the American Academy of Nurse Practitioners (AANP). AANP will accept AMA PRA Category 1 Credit™ from organizations accredited by the Accreditation Council for Continuing Medical Education. Nurse practitioners can also apply for credit through their state boards.
NASW Credit (Social Workers):
This program is Approved by the National Association of Social Workers (Approval # 886407722-6865 for 1 continuing education contact hours
CCMC Credit (Certified Case Managers):
This program has been approved for 1.5 hours by the Commission for Case Manager Certification (CCMC).
CPE Credit (Pharmacists):
CME Outfitters, LLC, is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. 1.5 contact hours (0.15 CEUs) Universal Activity Number:
Live: 0376-0000-18-023-L01-P
Enduring: 0376-0000-18-023-H01-P
Type: Knowledge-based
ABIM MOC Credit:
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.5 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
Learning Formats
Live activity
Enduring material
MIPS Improvement Activity: This activity counts towards MIPS Improvement Activity requirements under the Medicare Access and CHIP Reauthorization Act of 2015 (MACRA). Clinicians should submit their improvement activities by attestation via the CMS Quality Payment Program website.
Note to Physician Assistants: AAPA accepts certificates of participation for educational activities certified for AMA PRA Category 1 CreditTM from organizations accredited by the Accreditation Council for Continuing Medical Education.
Post-tests, credit request forms, and activity evaluations must be completed online at www.cmeoutfitters.com/TST28426 (requires free account activation), and participants can print their certificate or statement of credit immediately (75% pass rate required). This website supports all browsers except Internet Explorer for Mac. For complete technical requirements and privacy policy, visit www.neurosciencecme.com/technical.asp.
Disclosure Declaration
It is the policy of CME Outfitters, LLC, to ensure independence, balance, objectivity, and scientific rigor and integrity in all of their CE activities. Faculty must disclose to the participants any relationships with commercial companies whose products or devices may be mentioned in faculty presentations, or with the commercial supporter of this CE activity. CME Outfitters, LLC, has evaluated, identified, and attempted to resolve any potential conflicts of interest through a rigorous content validation procedure, use of evidence-based data/research, and a multidisciplinary peer review process. The following information is for participant information only. It is not assumed that these relationships will have a negative impact on the presentations.
Dr. Gold has no disclosures to report.
Dr. Berry has no disclosures to report
Dr. Fuehrlein has no disclosures to report
Dr. Kosten reports that he is a consultant for Alkermes; Amygdala Neurosciences, Inc.; Braeburn Pharmaceuticals, Inc.; GuidePoint Global, LLC; Indivior Inc.; MedaCorp; Novartis Pharmaceuticals Corporation; Promentis Pharmaceuticals, Inc.; US WorldMeds, LLC.
Dr. Wasser has no disclosures to report
Dr. Helfand (peer reviewer) has no disclosures to report.
Ms. Ochoa (peer reviewer) has no disclosures to report.
Jan Perez (planning committee) has no disclosures to report.
Sharon Tordoff (planning committee) has no disclosures to report.
Disclosures were obtained from the CME Outfitters, LLC staff: No disclosures to report.
Faculty of this CE activity may include discussions of products or devices that are not currently labeled for use by the FDA. The faculty have been informed of their responsibility to disclose to the audience if they will be discussing off-label or investigational uses (any uses not approved by the FDA) of products or devices.
Questions about this activity? Call us at 877.CME.PROS (877.263.7767).
TV-098-101018-90
